MOG Antibody-Induced CNS Demyelination: from Specificity to Function

A11

IgG antibodies (Abs) specific for central nervous system (CNS) antigens such as myelin oligoden-drocytes glycoprotein (MOG) are considered crucial effector molecules in some patients with mul-tiple sclerosis (MS) and related diseases. In the proposed project, we will characterize structural requirements for immune recognition of human MOG and determine IgG-Fc biophysical profiles and effector functions linked to in vivo pathogenicity of human MOG-Abs. In detail, these are our reseach questions:

    1. Do patients with circulating MOG-specific B cells particularly benefit from B cell depletion therapy?
    2. What are the structural requirements for immune recognition of human MOG?
    3. What are the Fc biophysical profiles and effector functions of human MOG-Abs?
    4. How do human MOG-Abs act pathogenetic in vivo?


Meyer et al. J. Immunol. 2013
Principal Investigators:

Prof. Dr. med. Edgard Meinl
Institut für Klinische Neuroimmunologie
LMU München
edgar.meinl@med.uni-muenchen.de

Univ.-Prof. Dr. med. Jan Lünemann
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster
jan.luenemann@ukmuenster.de

News

Thu, 15/09/2022
Photo gallery: Inflammation & Imaging Symposium in the MIC building
Muenster. From September 12th to 14th scientists from Muenster University and their international guests discussed the latest developments in research on inflammation and the imaging of the immune system at the 2nd Inflammation & Imaging Symposium. The annual event is jointly organised by several research networks from Münster, among them the CRC/TRR 128 “Multiple Sclerosis”. […]...more
Tue, 28/06/2022
CRC Retreat in Münster
Muenster. After a long pause, more than 90 participants of the CRC joined in Muenster Factory Hotel to update on the latest developments. We heard the most recent on a selection of the CRC projects and there was also plenty of time for fruitful discussion and socializing in the evening....more
Mon, 23/05/2022
EU Research Council awards Lydia Sorokin Advanced Grant
Münster – The biochemist and Principal investigator of the CRC 128 Prof. Dr. Lydia Sorokin has received the coveted “Advanced Grant” awarded by the European Research Council (ERC). The funding of ca. 2.3 million euros enables the realisation of outstanding research projects. Lydia Sorokin heads the Institute for Physiological Chemistry and Pathobiochemistry at Muenster University. […]...more